Iptacopan in Idiopathic Immune Complex–Mediated Membranoproliferative Glomerulonephritis: Protocol of the APPARENT Multicenter, Randomized Phase 3 Study

Vivarelli, Marina; Bomback, Andrew S.; Meier, Matthias; Wang, Yaqin; Webb, Nicholas J.A.; Veldandi, Uday Kiran; Smith, Richard J.H.; Kavanagh, David

doi:10.1016/j.ekir.2023.10.022

Kidney International Reports

2024

DOI: 10.1016/j.ekir.2023.10.022

|View full text |Cite

Iptacopan in Idiopathic Immune Complex–Mediated Membranoproliferative Glomerulonephritis: Protocol of the APPARENT Multicenter, Randomized Phase 3 Study

Marina Vivarelli,

Andrew S. Bomback,

Matthias Meier

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

2025

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 6 publications

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Glomerulonephritis mit MPGN-Muster und verwandte Formen

Hohenstein

2024

Nephrologie

View full text Add to dashboard Cite

Glomerulonephritis mit MPGN-Muster und verwandte Formen

Hohenstein

2024

Nephrologie

View full text Add to dashboard Cite

Iptacopan: First Approval

Syed

2024

Drugs

View full text Add to dashboard Cite

An oral complement Factor B inhibitor developed by Novartis Pharmaceuticals for the treatment of complement-mediated diseases • Received its first approval on 5 December 2023 in the USA • Approved for the treatment of adults with paroxysmal nocturnal haemoglobinuria This summary represents the opinions of the author. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online.

show abstract

Challenges in the Diagnosis and Management of Immune Complex-Mediated Membranoproliferative Glomerulonephritis and Complement 3 Glomerulopathy

Bomback,

Charu,

Fakhouri

2025

Kidney International Reports

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Iptacopan in Idiopathic Immune Complex–Mediated Membranoproliferative Glomerulonephritis: Protocol of the APPARENT Multicenter, Randomized Phase 3 Study

Cited by 6 publications

References 38 publications

Glomerulonephritis mit MPGN-Muster und verwandte Formen

Glomerulonephritis mit MPGN-Muster und verwandte Formen

Iptacopan: First Approval

Challenges in the Diagnosis and Management of Immune Complex-Mediated Membranoproliferative Glomerulonephritis and Complement 3 Glomerulopathy

Contact Info

Product

Resources

About